OR4D9 Inhibitors
OR4D9 inhibitors encompass a range of compounds that act on the ionic channels and neurotransmission pathways essential for the normal functioning of OR4D9 in olfactory signal transduction. Compounds such as quinidine and tetrodotoxin target voltage-gated sodium channels, which are crucial for action potential initiation and propagation in olfactory sensory neurons. Since OR4D9 is a G-protein coupled receptor involved in olfactory perception, the inhibition of these sodium channels would directly decrease the functional activity of OR4D9 by preventing the electrical changes necessary to respond to odorants.
Additionally, calcium channel blockers like Ruthenium Red, conotoxin, omega-conotoxin, cobalt(II) chloride, manganese(II) chloride, and amlodipine would inhibit the calcium signaling pathways that are integral to OR4D9's role in the olfactory system. Calcium influx is a key event following the binding of an odorant to OR4D9, leading to a cascade of intracellular events that ultimately result in olfactory perception.By inhibiting the voltage-gated sodium channels with agents such as quinidine, tetrodotoxin, and lidocaine, the generation and propagation of action potentials in olfactory sensory neurons are impaired, which is necessary for the activation and signal transduction of OR4D9. These compounds decrease OR4D9 activity by blocking the neuronal excitability that is a prerequisite for the receptor's proper engagement in the detection of odorants. The blockade of these channels by such compounds would lead to a reduced response of OR4D9 to odorants, as the receptor's activity is contingent on the electrophysiological state of its host neurons.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine blocks voltage-gated sodium channels, which are critical for the initiation and propagation of action potentials in olfactory sensory neurons. Inhibition of these channels by quinidine would prevent the activation of OR4D9, as it relies on the electrical activity of these neurons to initiate signal transduction. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is known to inhibit various calcium channels. Since calcium influx is essential for the olfactory signal transduction that engages OR4D9, the blockade of these channels by Ruthenium Red would hinder the ability of OR4D9 to participate in the detection of odorants. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine acts as a sodium channel blocker, which can inhibit the conduction of action potentials in neurons. This inhibition would reduce the activation of OR4D9 by impeding the electrical signaling required for its function in olfactory perception. | ||||||
Hexamethonium bromide | 55-97-0 | sc-205712 sc-205712A | 10 g 25 g | $46.00 $64.00 | ||
Hexamethonium, as a nicotinic receptor antagonist, can reduce cholinergic transmission. Although not directly related to OR4D9, the decreased neuronal excitability resulting from hexamethonium's action could indirectly decrease OR4D9's functional activity. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Bicuculline is a GABA_A receptor antagonist that, in excessive amounts, can lead to neuronal overstimulation and subsequent desensitization. This might indirectly dampen the activity of OR4D9 by reducing the overall excitability of olfactory neurons. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Cobalt(II) chloride can block calcium channels, thereby inhibiting the calcium influx necessary for the activation of olfactory signaling pathways involving OR4D9, leading to a decrease in its functional activity. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese ions can inhibit calcium channels by entering and blocking them. This inhibition would disrupt the calcium signaling on which OR4D9 relies for its activity in olfactory signaling. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Amlodipine is a calcium channel blocker that would inhibit the influx of calcium ions required for the activation of OR4D9 within the olfactory signal transduction pathways. | ||||||
Carbenoxolone | 5697-56-3 | sc-507294 | 1 g | $50.00 | ||
Carbenoxolone inhibits gap junctions, which could disrupt intercellular communication necessary for coordinated olfactory signaling. This could reduce the collective activity of OR4D9 across olfactory sensory neurons. | ||||||